Castration Resistant Prostate Cancer(CRPC)
CRPC is defined according to the Prostate Cancer Clinical Trials Working Group 2 as progression of prostate cancer despite castrate levels (<1.7 ng/ ml) of testosterone. Progression may be biochemical (three consecutive prostate specific antigen (PSA) rises >2 ng/ ml above nadir, minimum 1 wee...